Evidence map›Paper›PMID 42181103›Full record

ArticlePregnancy (Hoboken, N.J.)2026

The association of sociodemographic differences with clinical management following a diagnosis of short cervix.

Joseph R Biggio, Paula L McGee, George R Saade, Rebecca G Clifton, Monica Longo, Sabine Z Bousleiman, Kelly Clark, William A Grobman, Heather A Frey, Suneet P Chauhan and 8 more

Registry-linked trialAbstract read
In one paragraph

Article in Pregnancy (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02901626 (A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02901626 phase3terminatednot on this map

A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix

TypeinterventionalSponsorThe George Washington University Biostatistics CenterRan2017 to 2022Enrolled544ConditionsShort Cervix, Preterm DeliveryArmsArabin Cervical Pessary
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Joseph R BiggioDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, USA.ORCID 0000-0003-3748-7206
Paula L McGeeThe George Washington University Biostatistics Center, Washington, District of Columbia, USA.
George R SaadeDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Texas Medical Branch at Galveston, Galveston, Texas, USA.
Rebecca G CliftonThe George Washington University Biostatistics Center, Washington, District of Columbia, USA.
Monica LongoEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, USA.
Sabine Z BousleimanDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University, New York, New York, USA.
Kelly ClarkDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
William A GrobmanDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois, USA.
Heather A FreyDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, The Ohio State University, Columbus, Ohio, USA.
Suneet P ChauhanDivision of Maternal Fetal Medicine, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Texas Health Science at Houston McGovern Medical School, Houston, Texas, USA.
Lorraine DugoffDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0003-3638-036X
Tracy A ManuckDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Edward K ChienDivision of Maternal Fetal Medicine, Department of Reproductive Biology, Case Western Reserve University, Cleveland, Ohio, USA.
Dwight J RouseDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Brown University, Providence, Rhode Island, USA.
Hyagriv N SimhanDivision of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, The University of Pittsburgh Medical Center Magee-Womens Hospital, Pittsburgh, Pennsylvania, USA.
M Sean EsplinDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, Utah, USA.
George A MaconesDivision of Maternal Fetal Medicine, Department of Women's Health, University of Texas at Austin Dell Medical School, Austin, Texas, USA.
Matthew K HoffmanDivision of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University, New York, New York, USA.ORCID 0000-0002-2927-8693

Funding

SARS-CoV-2 Vaccine Pregnancy RegistryU24HD036801 · NICHD · GEORGE WASHINGTON UNIVERSITY · PI Rebecca Gersnoviez Clifton · 2021 to 2026
$39.2M
Maternal-Fetal Medicine Units (MFMU) NetworkUG1HD040485 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Noelia Milena Modad Zork · 2016 to 2026
$3.6M
NICHD Maternal Fetal Medicine Units NetworkUG1HD087192 · NICHD · UNIVERSITY OF PENNSYLVANIA · PI Lorraine Dugoff · 2016 to 2026
$3.6M
NICHD Maternal-Fetal Medicine Units (MFMU) NetworkUG1HD040544 · NICHD · CASE WESTERN RESERVE UNIVERSITY · PI Kelly S Gibson, Angela C. Ranzini · 2016 to 2026
$3.5M
Maternal-Fetal Medicine Units Network -- The Northwestern Study CenterUG1HD040512 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Lynn M Yee · 2016 to 2026
$3.4M
NICHD Maternal-Fetal Medicine Units (MFMU) NetworkUG1HD040500 · NICHD · WOMEN AND INFANTS HOSPITAL-RHODE ISLAND · PI DWIGHT J ROUSE · 2016 to 2026
$3.4M
UofU Maternal-Fetal Medicine Units (MFMU) Network: Clinical CentersUG1HD034208 · NICHD · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Torri D Metz · 2016 to 2026
$3.4M
NICHD Maternal Fetal Medicine Units NetworkUG1HD027915 · NICHD · OHIO STATE UNIVERSITY · PI Maged Costantine · 2016 to 2026
$3.3M
UNC MFMU: Advancing Perinatal Health via Definitive, Multi-Site Clinical StudiesUG1HD040560 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI John M Thorp · 2016 to 2026
$3.3M
NICHD Maternal-Fetal Medicine Units (MFMU) NetworkUG1HD087230 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HYAGRIV N SIMHAN · 2016 to 2026
$3.2M
NICHD Maternal-Fetal Medicine Units (MFMU) NetworkUG1HD040545 · NICHD · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Hector Mendez-Figueroa · 2016 to 2026
$3.2M
NICHD Maternal-Fetal Medicine Units NetworksUG1HD027869 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ALAN THEVENET N. TITA · 2016 to 2026
$3.0M
NICHD NIH HHS U24 HD036801NICHD NIH HHS UG1 HD027869NICHD NIH HHS UG1 HD027915NICHD NIH HHS UG1 HD034208NICHD NIH HHS UG1 HD040485NICHD NIH HHS UG1 HD040500NICHD NIH HHS UG1 HD040512NICHD NIH HHS UG1 HD040544NICHD NIH HHS UG1 HD040545NICHD NIH HHS UG1 HD040560NICHD NIH HHS UG1 HD053097NICHD NIH HHS UG1 HD087192NICHD NIH HHS UG1 HD087230
6 · The paper itself

Abstract

Introduction: Following diagnosis of a short cervix from 16 through 23 weeks there is considerable variation in clinical practice. We sought to evaluate the association of patient sociodemographic factors with variation in clinical management following diagnosis of a short cervix. Methods: This was a non-prespecified secondary analysis of the randomized Trial of Cervical Pessary for Short Cervix in Singleton Pregnancies (TOPS), in which individuals with singleton pregnancies with a cervical length (CL) ≤20 mm were randomized to either a pessary or usual care. We assessed recommendations for vaginal progesterone, additional CL surveillance, pelvic rest, bed rest, and cerclage. For individuals enrolled in the trial, additional CL assessment and cerclage were discouraged in the absence of significant cervical dilation; activity modification and vaginal progesterone were at provider's discretion. Sociodemographic factors assessed were self-reported race and ethnicity, marital status, employment status, years of education, and type of insurance. Multivariable regression models examined the association between each sociodemographic factor and management, adjusting for other sociodemographic factors, CL at enrollment, clinical center, and treatment arm; odds ratios (ORs) and 95% confidence intervals (CIs) were determined. Results: Of the 446 patients (82% of 544 enrolled in TOPS) with at least one post enrollment visit, 95.5% received vaginal progesterone, 28.0% had at least one additional CL assessment, 55.8% were placed on pelvic rest, 19.5% on activity restriction, and 7.4% underwent cerclage. The high rate of vaginal progesterone usage precluded evaluation of association with sociodemographic factors. Non-Hispanic Black and Hispanic patients had lower odds of repeat CL assessment compared with Non-Hispanic White patients (adjusted OR [aOR], 0.47; 95% CI, 0.24, 0.91; aOR, 0.45; 95% CI, 0.21, 0.99, respectively). No other sociodemographic factors were associated with repeat CL. Patients with private insurance, but no other factor, had higher odds of pelvic rest being recommended (aOR, 2.08; 95% CI, 1.25, 3.45). None of the examined sociodemographic factors were associated with recommendations for bed rest or cerclage. Conclusion: Following diagnosis of a short cervix, vaginal progesterone is prescribed for nearly all patients. Non-Hispanic Black and Hispanic patients were less likely to have a repeat CL assessment following diagnosis of a short cervix and those with private insurance were more likely to have pelvic rest recommended. Variation in the frequency of these interventions may reflect how sociodemographic and socially constructed factors can affect clinical decision making and implementation of interventions in the absence of definitive guidance. Trial registration: ClinicalTrials.gov Identifier: NCT02901626.

Indexed as

pelvic restpreterm birthshort cervixsociodemographic differencessystemic bias

Identifiers

PMID42181103
PMCPMC13196848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.